文献速递乳腺US

超声造影鉴别乳腺良恶性病变的诊断准确性:系统评价与Meta分析

Diagnostic accuracy of contrast-enhanced ultrasound to differentiate benign and malignant breast lesions: A systematic review and meta-analysis.
PubMed 文献 · Eur J Radiol · 2022-02-15

该系统评价与Meta分析检索了PubMed、Embase和Cochrane Library数据库,纳入29项研究共3050个乳腺病变,评估超声造影鉴别乳腺良恶性病变的合并诊断准确性。超声造影诊断恶性乳腺病变的合并敏感度为0.87(95%CI 0.81-0.90),特异度为0.79(95%CI 0.73-0.84),汇总诊断比值比为20.55(95%CI 14.11-29.93)。亚组分析提示患者年龄和造影剂可能影响诊断准确性,年轻患者或使用SonoVue造影剂时诊断价值更高。

要点

  • 超声造影诊断恶性乳腺病变的合并敏感度为0.87,特异度为0.79。
  • 阳性似然比4.17,阴性似然比0.17,汇总诊断比值比20.55。
  • 年轻患者或使用SonoVue造影剂时超声造影诊断价值更高。

核心结论

  • 超声造影鉴别乳腺良恶性病变具有较高的诊断准确性,年轻患者或使用SonoVue造影剂时诊断价值更高。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase和Cochrane Library数据库至2022年1月,纳入29项研究共3050个乳腺病变。

诊断标准与关键数值

  • 超声造影诊断恶性乳腺病变的合并敏感度为0.87(95%CI 0.81-0.90),特异度为0.79(95%CI 0.73-0.84)。
  • 阳性似然比为4.17(95%CI 3.21-5.42),阴性似然比为0.17(95%CI 0.12-0.24)。
  • 汇总诊断比值比为20.55(95%CI 14.11-29.93),Lambda值为3.18(95%CI 2.71-3.64)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the pooled diagnostic accuracy of contrast-enhanced ultrasound (CEUS) to differentiate benign and malignant breast lesions.

MATERIALS AND METHODS: Electronic databases of PubMed, Embase, and the Cochrane Library were searched for potentially eligible studies throughout January 2022. The potential effects of publication year, country, mean age, and contrast agents on the diagnostic accuracy of CEUS were also assessed.

RESULTS: Twenty-nine studies involving 3050 lesions were selected for the meta-analysis. The pooled sensitivity and specificity for CEUS diagnosing malignant breast lesions were 0.87 [95% confidence intervals (CI), 0.81-0.90] and 0.79 (95% CI, 0.73-0.84), respectively. The positive and negative likelihood ratios were 4.17 (95% CI, 3.21-5.42) and 0.17 (95% CI, 0.12-0.24), respectively. The summary diagnostic odds ratio of CEUS to differentiate benign and malignant breast lesions was 20.55 (95% CI, 14.11-29.93), and the Lambda of CEUS for detecting malignant breast lesions was 3.18 (95% CI, 2.71-3.64). Subgroup analyses showed that patients' age and contrast agents (Levovist, SonoVue, or other) might affect the diagnostic accuracy of CEUS used to differentiate benign and malignant breast lesions.

CONCLUSIONS: CEUS had a relatively high diagnostic accuracy to differentiate benign and malignant breast lesions. Moreover, the diagnostic value of CEUS in younger patients or those using SonoVue as contrast agents was higher than that in the corresponding subgroups.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang, Zhao, Cheng, et al. Diagnostic accuracy of contrast-enhanced ultrasound to differentiate benign and malignant breast lesions: A systematic review and meta-analysis. Eur J Radiol. 2022. PMID: 35228171. doi:10.1016/j.ejrad.2022.110219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。